These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 31645370)

  • 1. Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.
    Honda A; Miyazaki T; Iwamoto J; Hirayama T; Morishita Y; Monma T; Ueda H; Mizuno S; Sugiyama F; Takahashi S; Ikegami T
    J Lipid Res; 2020 Jan; 61(1):54-69. PubMed ID: 31645370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human-like bile acid pool induced by deletion of hepatic
    de Boer JF; Verkade E; Mulder NL; de Vries HD; Huijkman N; Koehorst M; Boer T; Wolters JC; Bloks VW; van de Sluis B; Kuipers F
    J Lipid Res; 2020 Mar; 61(3):291-305. PubMed ID: 31506275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury.
    Truong JK; Bennett AL; Klindt C; Donepudi AC; Malla SR; Pachura KJ; Zaufel A; Moustafa T; Dawson PA; Karpen SJ
    J Lipid Res; 2022 Sep; 63(9):100261. PubMed ID: 35934110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70
    Li R; Palmiotti A; de Vries HD; Hovingh MV; Koehorst M; Mulder NL; Zhang Y; Kats K; Bloks VW; Fu J; Verkade HJ; de Boer JF; Kuipers F
    J Lipid Res; 2021; 62():100134. PubMed ID: 34626589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human-Like Bile Acid Composition.
    Iwamoto J; Honda A; Miyazaki T; Monma T; Ueda H; Morishita Y; Yara SI; Hirayama T; Ikegami T
    Hepatol Commun; 2021 Dec; 5(12):2052-2067. PubMed ID: 34558859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition.
    Verkade E; Shen W; Hovingh MV; Mulder NL; de Bruyn K; Koehorst M; de Vries HD; Bloks VW; Kuipers F; de Boer JF
    Clin Sci (Lond); 2023 Nov; 137(21):1637-1650. PubMed ID: 37910096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition.
    Ueda H; Honda A; Miyazaki T; Morishita Y; Hirayama T; Iwamoto J; Nakamoto N; Ikegami T
    PLoS One; 2022; 17(7):e0271308. PubMed ID: 35819971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis.
    Umemura M; Honda A; Yamashita M; Chida T; Noritake H; Yamamoto K; Honda T; Ichimura-Shimizu M; Tsuneyama K; Miyazaki T; Kurono N; Leung PSC; Gershwin ME; Suda T; Kawata K
    J Autoimmun; 2024 Sep; 148():103287. PubMed ID: 39033687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acid homeostasis in female mice deficient in
    Rizzolo D; Kong B; Taylor RE; Brinker A; Goedken M; Buckley B; Guo GL
    Acta Pharm Sin B; 2021 Dec; 11(12):3847-3856. PubMed ID: 35024311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Of mice and men: murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism.
    Straniero S; Laskar A; Savva C; Härdfeldt J; Angelin B; Rudling M
    J Lipid Res; 2020 Apr; 61(4):480-491. PubMed ID: 32086245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual bile acids have differential effects on bile acid signaling in mice.
    Song P; Rockwell CE; Cui JY; Klaassen CD
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid.
    de Boer JF; de Vries HD; Palmiotti A; Li R; Doestzada M; Hoogerland JA; Fu J; La Rose AM; Westerterp M; Mulder NL; Hovingh MV; Koehorst M; Kloosterhuis NJ; Wolters JC; Bloks VW; Haas JT; Dombrowicz D; Staels B; van de Sluis B; Kuipers F
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1045-1069. PubMed ID: 33309945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
    Fu ZD; Klaassen CD
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
    Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism.
    Hu X; Bonde Y; Eggertsen G; Rudling M
    J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model.
    Taylor R; Yang Z; Henry Z; Capece G; Meadows V; Otersen K; Basaly V; Bhattacharya A; Mera S; Zhou P; Joseph L; Yang I; Brinker A; Buckley B; Kong B; Guo GL
    Toxicol Sci; 2024 May; 199(2):316-331. PubMed ID: 38526215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE is a major determinant of hepatic bile acid homeostasis in mice.
    von Hardenberg S; Gnewuch C; Schmitz G; Borlak J
    J Nutr Biochem; 2018 Feb; 52():82-91. PubMed ID: 29175670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition.
    Li R; Hovingh MV; Koehorst M; de Blaauw P; Verkade HJ; de Boer JF; Kuipers F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159163. PubMed ID: 35470044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice.
    Hasan MN; Chen J; Matye D; Wang H; Luo W; Gu L; Clayton YD; Du Y; Li T
    J Lipid Res; 2023 Mar; 64(3):100340. PubMed ID: 36737039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.